Synchronicity Pharma, Inc. — Form D
Synchronicity Pharma, Inc. of SAN JOSE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-25. The offering totals $3.0M, of which $1.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-01-25
- Form: D
- Accession: 0001593318-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.6M
- Remaining: $1.4M
- Investors: 3
- Date of first sale: 2022-01-11
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-430716
Issuer
- Name: Synchronicity Pharma, Inc.
- CIK: 0001593318
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1416 Saratoga Avenue, SAN JOSE, CA, 95129
- Phone: (650) 235-4140
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Glenn B Batchelder | Director | San Jose, CA |
| Frederick B Craves | Director | San Jose, CA |
| Blair B Jackson | Director | San Jose, CA |
| Steve B Kay | Director | San Jose, CA |
| Glenn B Batchelder | Executive Officer | San Jose, CA |
| Shu B Kurosaki | Executive Officer | #133, CA |
| Shuichi B Kurosaki | Executive Officer | San Jose, CA |
| Hoyoung B Huh | Director | South San Francisco, CA |
| Ross Bersot | Director | San Francisco, CA |
| Ross Bersot | Executive Officer | San Francisco, CA |
| Peter B Schultz | Director | South San Francisco, CA |
| Paul B Humphries | Executive Officer | South San Francisco, CA |
Other filings by this issuer (8)
More